Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IGL
|
|||
| Former ID |
DNC009201
|
|||
| Drug Name |
(+/-)-3-allyl-1-pent-4-enoylazetidin-2-one
|
|||
| Synonyms |
CHEMBL487448; (+/-)-3-allyl-1-pent-4-enoylazetidin-2-one; 1-(4'-pentenoyl)-3-(2'-propenyl)-2-azetidinone; BDBM50243198
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H15NO2
|
|||
| Canonical SMILES |
C=CCCC(=O)N1CC(C1=O)CC=C
|
|||
| InChI |
1S/C11H15NO2/c1-3-5-7-10(13)12-8-9(6-4-2)11(12)14/h3-4,9H,1-2,5-8H2
|
|||
| InChIKey |
QVTWEMBUZOBMIJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors. Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.